1. Home
  2. SER vs BEDU Comparison

SER vs BEDU Comparison

Compare SER & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • BEDU
  • Stock Information
  • Founded
  • SER 2017
  • BEDU 1994
  • Country
  • SER United States
  • BEDU United Kingdom
  • Employees
  • SER N/A
  • BEDU N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • BEDU Other Consumer Services
  • Sector
  • SER Health Care
  • BEDU Real Estate
  • Exchange
  • SER Nasdaq
  • BEDU Nasdaq
  • Market Cap
  • SER 56.5M
  • BEDU 54.3M
  • IPO Year
  • SER 2018
  • BEDU 2017
  • Fundamental
  • Price
  • SER $5.11
  • BEDU $1.70
  • Analyst Decision
  • SER Strong Buy
  • BEDU
  • Analyst Count
  • SER 2
  • BEDU 0
  • Target Price
  • SER $13.00
  • BEDU N/A
  • AVG Volume (30 Days)
  • SER 326.5K
  • BEDU 1.4K
  • Earning Date
  • SER 08-11-2025
  • BEDU 11-25-2025
  • Dividend Yield
  • SER N/A
  • BEDU N/A
  • EPS Growth
  • SER N/A
  • BEDU N/A
  • EPS
  • SER N/A
  • BEDU N/A
  • Revenue
  • SER $130,000.00
  • BEDU $224,321,752.00
  • Revenue This Year
  • SER N/A
  • BEDU N/A
  • Revenue Next Year
  • SER N/A
  • BEDU N/A
  • P/E Ratio
  • SER N/A
  • BEDU N/A
  • Revenue Growth
  • SER N/A
  • BEDU N/A
  • 52 Week Low
  • SER $3.81
  • BEDU $1.35
  • 52 Week High
  • SER $10.28
  • BEDU $2.19
  • Technical
  • Relative Strength Index (RSI)
  • SER 44.13
  • BEDU 44.10
  • Support Level
  • SER $5.00
  • BEDU $1.71
  • Resistance Level
  • SER $5.49
  • BEDU $1.73
  • Average True Range (ATR)
  • SER 0.53
  • BEDU 0.04
  • MACD
  • SER -0.01
  • BEDU -0.01
  • Stochastic Oscillator
  • SER 12.36
  • BEDU 9.68

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom and the United States. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.

Share on Social Networks: